Skip to content

Effect of Citrus Aurantium extract on painful menstruation

Comparison of the effect of Citrus Aurantium extract with Mefenamic Acid on the intensity of Primary Dismenorrhea

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180524039815N1
Enrollment
105
Registered
2018-05-31
Start date
2018-06-22
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Citrus Aurantium extract 250 mg capsule every 8 hours during the first three days of the cycle. Intervention 2: Intervention group: Mefenamic Acid 250 mg capsule ev

Sponsors

Deputy of Research of Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 20 Years

Inclusion criteria

Inclusion criteria: Being single-Age from 15 to 20 Having Primary Dysmenorrhea with moderate to severe intensity accourding to Mcgill pain scale atleast for the last cycle Regular distance between menstrual cycles No previous abdominal or pelvic surgery No symptomes like irritation, burning or abnormal vaginal secretions No past history of pelvic inflammatory disease,Endometriosis,Myoma and tumor No stressful situations like death of first degree relatives, seperation of parents,... in the last 6 months.

Exclusion criteria

Exclusion criteria: Unwillingness to take medication for different reasons like severe side effects or discontent Using any medicine or herbal product Being allergic to Citrus Aurantium flower.

Design outcomes

Primary

MeasureTime frame
Intensity of Dysmenorrhea. Timepoint: Monthly. Method of measurement: Visual Analogue Scale(VAS) - Mcgill pain scale.;Days of bleeding. Timepoint: Daily. Method of measurement: Questionnaire.;Distance between two cycles. Timepoint: Day. Method of measurement: Questionnaire.;Physical activity. Timepoint: Monthly. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Complications of interventions. Timepoint: During intervention. Method of measurement: Questionnaire-Report-Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Parvin Bastani

Tabriz University of Medical Sciences

Bastani.parvin@yahoo.com+98 41 3331 0477

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026